Skip to main content
Fig. 10 | Cancer Cell International

Fig. 10

From: The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing data

Fig. 10

Gene alteration of UBE2C in BRCA. a The OncoPrint schematic showed that gene alteration of UBE2C occurred in 118 (11%) of all 1098 sequenced cases, including 30 cases of amplification, one case of deep deletion, 19 cases of mRNA down-regulation, 80 cases of mRNA up-regulation and 12 cases of a mixed type of amplification and mRNA up-regulation; Kaplan–Meier survival curves for overall survival and disease-free survival showed that there was no significant correlation between gene alteration of UBE2C and the overall survival (b) as well as the disease-free survival (c) of BRCA patients

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us